Skip to main content
Journal cover image

Use of Virtual Oncology in Hepatopancreatobiliary Cancers: A Scoping Review.

Publication ,  Journal Article
Thota, HB; Kulkarni, A; Lee, R; Tuttle, B; Lidsky, ME; Shah, KN; Allen, PJ; Martin, AN
Published in: Ann Surg Oncol
January 2026

BACKGROUND: Telehealth has emerged as a promising solution to address access gaps in cancer care, particularly for complex conditions such as hepatopancreatobiliary (HPB) cancers. Despite the broader adoption of telemedicine in oncology, HPB cancers remain underrepresented in digital health innovation. This scoping review aimed to characterize the extent, nature, and outcomes of telehealth interventions for HPB cancers. METHODS: From the inception of telehealth to 16 January 2025, a medical librarian searched the MEDLINE, Embase, and Web of Science databases for studies on telehealth use in the HPB oncology patient population. Two reviewers screened studies in a dual-review process. The included studies examined telehealth for screening, treatment or surveillance, and reported feasibility, health outcomes, cost-effectiveness, and satisfaction in academic, community, or government health care settings. RESULTS: Of 5049 articles identified, 42 met the inclusion criteria. Most study designs were observational (cohort) or pilot feasibility trials focusing on patient-facing interventions such as mobile apps, symptom monitoring, and virtual consultations. Fewer studies evaluated provider-facing models such as virtual tumor boards or inter-institutional consultations. The most frequently assessed outcomes were feasibility (n = 28), health outcomes (n = 24), and satisfaction (n = 22), with minimal evaluation of cost-effectiveness (n = 3). Most of the studies were conducted in academic or urban settings, with only one study focusing on a rural population. CONCLUSION: Telehealth for HPB cancers remains nascent, with interventions largely concentrated in high-resource, urban environments. Given the complexity of HPB care and the significant disparities in access, future efforts should prioritize the development of multidisciplinary, equity-oriented virtual platforms tailored to HPB populations.

Duke Scholars

Published In

Ann Surg Oncol

DOI

EISSN

1534-4681

Publication Date

January 2026

Volume

33

Issue

1

Start / End Page

624 / 637

Location

United States

Related Subject Headings

  • Telemedicine
  • Pancreatic Neoplasms
  • Oncology & Carcinogenesis
  • Medical Oncology
  • Liver Neoplasms
  • Humans
  • Cost-Benefit Analysis
  • Biliary Tract Neoplasms
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Thota, H. B., Kulkarni, A., Lee, R., Tuttle, B., Lidsky, M. E., Shah, K. N., … Martin, A. N. (2026). Use of Virtual Oncology in Hepatopancreatobiliary Cancers: A Scoping Review. Ann Surg Oncol, 33(1), 624–637. https://doi.org/10.1245/s10434-025-18336-z
Thota, Hima Bindu, Anagh Kulkarni, Rachel Lee, Brandi Tuttle, Michael E. Lidsky, Kevin N. Shah, Peter J. Allen, and Allison N. Martin. “Use of Virtual Oncology in Hepatopancreatobiliary Cancers: A Scoping Review.Ann Surg Oncol 33, no. 1 (January 2026): 624–37. https://doi.org/10.1245/s10434-025-18336-z.
Thota HB, Kulkarni A, Lee R, Tuttle B, Lidsky ME, Shah KN, et al. Use of Virtual Oncology in Hepatopancreatobiliary Cancers: A Scoping Review. Ann Surg Oncol. 2026 Jan;33(1):624–37.
Thota, Hima Bindu, et al. “Use of Virtual Oncology in Hepatopancreatobiliary Cancers: A Scoping Review.Ann Surg Oncol, vol. 33, no. 1, Jan. 2026, pp. 624–37. Pubmed, doi:10.1245/s10434-025-18336-z.
Thota HB, Kulkarni A, Lee R, Tuttle B, Lidsky ME, Shah KN, Allen PJ, Martin AN. Use of Virtual Oncology in Hepatopancreatobiliary Cancers: A Scoping Review. Ann Surg Oncol. 2026 Jan;33(1):624–637.
Journal cover image

Published In

Ann Surg Oncol

DOI

EISSN

1534-4681

Publication Date

January 2026

Volume

33

Issue

1

Start / End Page

624 / 637

Location

United States

Related Subject Headings

  • Telemedicine
  • Pancreatic Neoplasms
  • Oncology & Carcinogenesis
  • Medical Oncology
  • Liver Neoplasms
  • Humans
  • Cost-Benefit Analysis
  • Biliary Tract Neoplasms
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis